Power3 Medical Products In Talks With Industry Leaders To License And Market Its Proprietary Technology for Diagnostic, Disease Detection Blood Tests For Breast Cancer, Alzheimer’s And Parkinson’s Disease

HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), today announced that the Company has been contacted by and is currently in talks with leading marketers of early disease detection tests and is confident that the ongoing talks and negotiations will insure the future of the company’s primary focus, the commercialization of its proprietary intellectual property, and to enhance shareholder value through product sales and new revenue streams.
MORE ON THIS TOPIC